Table 1.

Summary of Clinical Characteristics of the Seven Patients With COVID-19

	Patient 1	Patient 2	Patient 3	Patient 4	Patient 5	Patient 6	Patient 7
Age (y)	63	57	68	57	61	60	56
Sex	Male	Male	Male	Male	Male	Female	Female
Smoking history	Current	Never	Ever	Current	Current	Never	Never
Resident of Wuhan	Yes	No	Yes	No	No	No	No
Comorbidity	Interstitial lung disease	Coronary atherosclerosis	COPD	COPD	None	Hyperlipidemia + coronary atherosclerosis	Coronary atherosclerosis
FEV1 (L)	2.5	3.07	1.39	2.36	2.42	2.04	2.77
FEV1/FVC (%)	70.01	75.11	58.52	65.09	83.32	85	72.51
Tumor location	RLL	LLL	RLL	RUL	LUL	LUL (GGN) LLL (GGN)	RLL
Tumor size (cm)	3.5	5.0	1.7	1.5	3.5	LUL: 1.0 LLL: 1.7	3.5
Operation	RLL lobectomy	LLL lobectomy + S4 + 5 sleeve resection	RLL lobectomy + reconstruction of the right bronchus intermedius	RUL lobectomy	LUL lobectomy	LUL: wedge resection LLL: basal segmentectomy	RLL lobectomy
Lymphadenectomy	Yes	Yes	Yes	Yes	Yes	Yes	No
Approach	VATS	Open	Open	VATS	VATS	VATS	VATS
Duration of surgery (min)	200	220	280	165	150	130	110
Blood loss (mL)	130	100	200	100	50	50	100
Histologic type	SCC	Ade	Ade	Ade	Ade	LUL: Ade LLL: Ade	PSP
Tumor stage	pT2aN0M0R0	pT2N2M0R0	pT1N2M0R0	pT1bN0M0R0	pT2N2M0R0	LUL: T1aN0M0R0 LLL: T1bN0M0R0	NA

Ade, adenocarcinoma; COPD, chronic obstructive pulmonary disease; COVID-19, coronavirus disease 2019; FEV₁, forced expiratory volume in 1 second; FVC, forced vital capacity; GGN, ground-glass nodule; LLL, left lower lobe; LUL, left upper lobe; NA, not applicable; PSP, pulmonary sclerosing pneumocytoma; RLL, right lower lobe; RUL, right upper lobe; SCC, squamous cell carcinoma; VATS, video-assisted thoracic surgery.